Evidence map›Paper›PMID 39794447›Full record

ArticleEMBO molecular medicine2025

Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease.

Davina Biel, Marc Suárez-Calvet, Anna Dewenter, Anna Steward, Sebastian N Roemer, Amir Dehsarvi, Zeyu Zhu, Julia Pescoller, Lukas Frontzkowski, Annika Kreuzer and 4 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  9. Article
  10. A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Davina BielInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany. Davina.Biel@med.uni-muenchen.de.ORCID 0000-0002-2597-1992
Marc Suárez-CalvetBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.ORCID 0000-0002-2993-569X
Anna DewenterInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Anna StewardInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-8438-3760
Sebastian N RoemerInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-3423-457X
Amir DehsarviInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-7116-9741
Zeyu ZhuInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Julia PescollerInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Lukas FrontzkowskiInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Annika KreuzerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Christian HaassGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID 0000-0002-4869-1627
Michael SchöllUniversity of Gothenburg, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Mölndal and Gothenburg, Sweden.ORCID 0000-0001-7800-1781
Matthias Brendel *Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Nicolai Franzmeier *Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-9736-2283

Funding

LMU, FoeFoLe 1119SyNergy excellence cluster EXC 2145/ID 390857198
6 · The paper itself

Abstract

In Alzheimer's disease (AD), Aβ triggers p-tau secretion, which drives tau aggregation. Therefore, it is critical to characterize modulators of Aβ-related p-tau increases which may alter AD trajectories. Here, we assessed whether factors known to alter tau levels in AD modulate the association between fibrillar Aβ and secreted p-tau

Indexed as

Alzheimer DiseaseMembrane GlycoproteinsReceptors, Immunologictau ProteinsAgedAged, 80 and overAmyloid beta-PeptidesApolipoprotein E4Cross-Sectional StudiesFemaleHumansMaleMiddle AgedSex FactorsAmyloid beta-PeptidesApolipoprotein E4MAPT protein, humanMembrane GlycoproteinsReceptors, Immunologictau ProteinsTREM2 protein, humanAlzheimer’s DiseaseMicrogliap-tauSex DifferencessTREM2

Identifiers

PMID39794447
PMCPMC11822105

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.